Precision Biosciences Inc

NASDAQ:DTIL   9:30:31 AM EDT
12.65
+0.02 (+0.16%)
Other Pre-Announcement

Precision Biosciences Reports Second Quarter 2021 Financial Results And Provides Business Update

Published: 08/12/2021 11:24 GMT
Precision Biosciences Inc (DTIL) - Precision Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Revenue $68.8 Million.
Q2 Revenue Estimate $13.9 Million -- Refinitiv Ibes Data (analyst estimates).
Precision Biosciences - Expects Existing Cash, Cash Equivalents, to Be Sufficient to Fund Operating Expenses, Capex Requirements Into 2023.
Qtrly Earnings per Share $0.36.